Allergan Entertaining Offer From Actavis Over $200 Per ShareMark Melin
Bloomberg is reporting that Actavis plc (NYSE:ACT) is in talks to acquire Allergan, Inc. (NYSE:AGN) for a price north of $200 per share. Allergan is said to want over $210 per share while Actavis is said to currently be willing to pay just over $200 per share, approximately a $3 . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible